Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.34 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.34 |
| ▸ | SOS2 | Q07890 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | RAB9A | P51151 | 2/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.32 |
| ▸ | RELA | Q04206 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1438872 | 0.94 | ACHE (0.41) | ACHESOS1SOS2HDAC6MAPT | |
| SCHEMBL1438685 | 0.70 | — | — | |
| SCHEMBL1126763 | 0.68 | KDM4E (0.51) | MAPTALDH1A1L3MBTL1MEN1KMT2A | |
| SCHEMBL3022168 | 0.68 | ALDH1A1 (0.35) | PDPK1MAPTALDH1A1HSD17B10L3MBTL1 | |
| SCHEMBL14249861 | 0.67 | CA1 (0.34) | ACHESOS1SOS2MAPTHSD17B10 | |
| SCHEMBL15473984 | 0.67 | CYP1A2 (0.36) | CYP1A2 | |
| SCHEMBL21765805 | 0.66 | ACHE (0.40) | ACHEMAPTALDH1A1HSD17B10L3MBTL1 | |
| SCHEMBL14248892 | 0.65 | BUB1 (0.33) | MAPTALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL12810523 | 0.65 | ACHE (0.33) | ACHE | |
| SCHEMBL14249410 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12410164-B2 | Heterocyclic compounds and medical use thereof | FONDAZIONE TELETHON (IT) | 2025-09-09 | — | — | US | disclosed |
| US-11667643-B2 | RIP1K inhibitors | RIGEL PHARMACEUTICALS, INC. (US) | 2023-06-06 | — | — | US | disclosed |
| WO-2012172093-A1 | DIHYDROINDOLIZINE DERIVATE AS METABOTROPIC GLUTAMATE RECEPTOR MODULATORS | MERZ PHARMA GMBH & CO. KGAA (DE) | 2012-12-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11667643-B2 | RIP1K inhibitors | RIPK1, RIPK2, RIPK3 | ACHE 4664/4885PDPK1 49/4885SOS1 2385/4885 |
| US-12410164-B2 | Heterocyclic compounds and medical use thereof | NPPA, NPR1, CYC1 | ACHE 1359/4885PDPK1 3724/4885SOS1 1988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.